Management of Medication-related Osteonecrosis of the Jaw, An Issue of Oral and Maxillofacial Clinics of North America 27-4

Salvatore L. Ruggiero

Description

Editor Salvatore Ruggiero, DMD, MD and authors review the Diagnosis, Management and Prevention of Medication-related Osteonecrosis of the Jaw. Articles will include: Osteoporosis and bone modulation therapies: indications and outcomes; Antiresorptive therapies for the treatment of malignant osteolytic bone disease; Clinical presentation and staging of antiresorptive agent-induced osteonecrosis of the jaw; Epidemiology and risk factors of antiresorptive agent-induced osteonecrosis of the jaw; Basic science research of antiresorptive agent-induced osteonecrosis of the jaw: an update; Pathophysiology of antiresorptive agent-induced osteonecrosis of the jaw: what we know and what we don’t know; The genetics of osteonecrosis of the jaw; Preventive strategies for patients at risk of antiresorptive agent-induced osteonecrosis of the jaw; Non-operative and operative therapies for treatment of antiresorptive agent-induced osteonecrosis of the jaw; The role of anti-angiogenic therapy in the development of osteonecrosis of the jaw; Antiresorptive therapies: what they are and how do they work, and more!

Sujets

• Médecine
• Médecine Générale
• Oral Surgery
• Medical
• Dentistry

Informations

• Publié par: Elsevier
• Date de parution: 07 janvier 2016
• Nombre de lectures: 0
• EAN13: 9780323413473
• Langue: English
• Poids de l'ouvrage: 2 Mo

Extrait

Management of Medication-related Osteonecrosis of the Jaw
Oral and Maxillofacial Surgery Clinics of North America
Editor
Salvatore L. Ruggiero, DMD, MD, FACS
New York Center for Orthognathic and Maxillofacial Surgery, Lake Success, NY, USA
Consulting Editor
Richard H. Haug

Clinics Review Articles

www.oralmaxsurgery.theclinics.com

November 2015 Volume 27 Number 4
Table of Contents
Cover image
Title page
Copyright
Contributors
Consulting Editor
Editor
Authors
Forthcoming Issues
Forthcoming Issues
Recent Issues
Preface
Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw
Key points
Introduction
Nomenclature and diagnostic criteria
Clinical presentation
Imaging
Histopathology
Clinical staging
Summary
References
Pathophysiology of Osteonecrosis of the Jaws
Key points
Introduction
Proposed hypotheses of medication-related osteonecrosis of the jaw pathophysiology
Summary
References
Medication-Related Osteonecrosis of the Jaw: Basic and Translational Science Updates
Key points
Introduction
Medication-related osteonecrosis of the jaw at the cell level-bisphosphonate action on cells and tissue accumulation
Animal models of medication-related osteonecrosis of the jaw: the toolbox is full and ready to be put to work
Where do we go from here?
References
The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors
Key points
Introduction
Summary of findings
Risk factors for medication-related osteonecrosis of the jaws
Summary
References
Management of Medication-Related Osteonecrosis of the Jaw
Key points
Introduction
Medical management
Surgical management
Summary
References
Preventive Strategies for Patients at Risk of Medication-related Osteonecrosis of the Jaw
Key points
Introduction
Patients at risk
Preventive strategies before commencement of antiresorptives
Preventive strategies after commencement of antiresorptives
Summary
References
Pharmacogenetics of Bisphosphonate-associated Osteonecrosis of the Jaw
Key points
Introduction
Pharmacogenetics and adverse drug reactions
Genome-wide association studies on osteonecrosis of the jaw
Candidate gene studies on osteonecrosis of the jaw
Summary
References
The Role of Antiangiogenic Therapy in the Development of Osteonecrosis of the Jaw
Key points
Introduction
Medication-related osteonecrosis of the jaws in patients receiving the vascular endothelial growth factor inhibitor bevacizumab, with and without antiresorptive exposure
Medication-related osteonecrosis of the jaws in patients receiving tyrosine kinase inhibitors, with and without antiresorptive exposure
Medication-related osteonecrosis of the jaws in patients receiving mammalian target of rapamycin inhibitors with or without antiresorptive medications
Medication-related osteonecrosis of the jaws and immunomodulatory agents with an antiangiogenic profile
Summary
References
Antiresorptive Therapies for Osteoporosis
Key points
References
Antiresorptive Therapies for the Treatment of Malignant Osteolytic Bone Disease
Key points
Introduction
Pamidronate
Zoledronic acid (zoledronate)
Denosumab
Summary
References
Indications and Outcomes of Osteoporosis and Bone Modulation Therapies
Key points
References
Index
Copyright
ELSEVIER
1600 John F. Kennedy Boulevard Suite 1800 Philadelphia, Pennsylvania, 19103-2899
http://www.oralmaxsurgery.theclinics.com
ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA Volume 27, Number 4
November 2015 ISSN 1042-3699, ISBN-13: 978-0-323-41346-6
Editor: John Vassallo; [e-mail]
Developmental Editor: Colleen Viola
2015 Elsevier Inc. All rights reserved.
This periodical and the individual contributions contained in it are protected under copyright by Elsevier, and the following terms and conditions apply to their use:
Photocopying
Single photocopies of single articles may be made for personal use as allowed by national copyright laws. Permission of the Publisher and payment of a fee is required for all other photocopying, including multiple or systematic copying, copying for advertising or promotional purposes, resale, and all forms of document delivery. Special rates are available for educational institutions that wish to make photocopies for non-profit educational classroom use. For information on how to seek permission visit www.elsevier.com/permissions or call: ([phone] (UK)/([phone] (USA).
Derivative Works
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations (please consult www.elsevier.com/permissions ).
Electronic Storage or Usage
Permission of the Publisher is required to store or use electronically any material contained in this periodical, including any article or part of an article (please consult www.elsevier.com/permissions ). Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher.
Notice
No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made.
Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Oral and Maxillofacial Surgery Clinics of North America (ISSN 1042-3699) is published quarterly by Elsevier Inc., 360 Park Avenue South, New York, NY 10010-1710. Months of issue are February, May, August, and November. Business and Editorial Offices: 1600 John F. Kennedy Blvd., Suite 1800, Philadelphia, PA 19103-2899. Periodicals postage paid at New York, NY and additional mailing offices. Subscription prices are $385.00 per year for US individuals, $567.00 per year for US institutions, $175.00 per year for US students and residents, $455.00 per year for Canadian individuals, $680.00 per year for Canadian institutions, $520.00 per year for international individuals, $680.00 per year for international institutions and $235.00 per year for Canadian and foreign students/residents. To receive student/resident rate, orders must be accompanied by name or affiliated institution, date of term, and the signature of program/residency coordinator on institution letterhead. Orders will be billed at individual rate until proof of status is received. Foreign air speed delivery is included in all Clinics subscription prices. All prices are subject to change without notice. POSTMASTER: Send address changes to Oral and Maxillofacial Surgery Clinics of North America, Elsevier Periodicals Customer Service, 11830 Westline Industrial Drive, St. Louis, MO 63146. Tel: [phone] (U.S. and Canada); 314-447-8871 (outside U.S. and Canada). Fax: [phone]. E-mail: [e-mail] (for print support); [e-mail] (for online support) .
Reprints. For copies of 100 or more, of articles in this publication, please contact the Commercial Reprints Department, Elsevier Inc., 360 Park Avenue South, New York, NY 10010-1710. Tel.: [phone]; Fax: [phone]; Email: [e-mail] .
Oral and Maxillofacial Surgery Clinics of North America is covered in MEDLINE/PubMed ( Index Medicus ), Science Citation Index Expanded (SciSearch ) , Journal Citation Reports/Science Edition , and Current Contents /Clinical Medicine .
Printed in the United States of America.
Contributors
Consulting Editor
RICHARD H. HAUG, DDS , Professor and Chief, Oral Maxillofacial Surgery, Carolinas Medical Center, Charlotte, North Carolina
Editor
SALVATORE L. RUGGIERO, DMD, MD, FACS , New York Center for Orthognathic and Maxillofacial Surgery, Lake Success; Clinical Professor, Department of Oral and Maxillofacial Surgery, Stony Brook University, Stony Brook; Clinical Professor, Department of Dental Medicine, Hofstra North Shore-LIJ School of Medicine, New Hyde Park, New York
Authors
TARA AGHALOO, DDS, MD, PhD , Professor and Assistant Dean for Clinical Research, Section of Oral and Maxillofacial Surgery, Division of Diagnostic and Surgical Sciences, UCLA School of Dentistry, Los Angeles, California
MATTHEW R. ALLEN, PhD , Associate Professor, Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, Indiana
THOMAS B. DODSON, DMD, MPH , Professor and Chair; Associate Dean for Hospital Affairs, Department of Oral and Maxillofacial Surgery, University of Washington School of Dentistry, Seattle, Washington
JOHN E. FANTASIA, DDS , Professor, Division of Oral and Maxillofacial Pathology, Department of Dental Medicine, Hofstra North Shore-LIJ School of Medicine, New Hyde Park, New York
S. FEDELE, DDS, PhD , UCL Eastman Dental Institute, University College London; Biomedical NIHR Research Centre, University College London Hospitals, London, United Kingdom
P.L. FUNG, BDS, MSc, PhD , UCL Eastman Dental Institute, University College London, London, United Kingdom
REGINALD H. GOODDAY, DDS, MSc, FRCD(C), FICD, FACD , Professor, Department of Oral and Maxillofacial Sciences, Faculty of Dentistry, Dalhousie University